TLCR Reading Tools
How to cite item
Immune checkpoint inhibitors combined with tyrosine kinase inhibitors is the treatment option of previously treated advanced non-small cell lung cancer harboring EGFR or ALK genetic aberration
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{TLCR}{68883}, author = {Yang, X., Zhu, C., Zhao, H.}, title = {Immune checkpoint inhibitors combined with tyrosine kinase inhibitors is the treatment option of previously treated advanced non-small cell lung cancer harboring EGFR or ALK genetic aberration}, journal = {Translational Lung Cancer Research}, volume = {11}, number = {10}, year = {2022}, url = {https://tlcr.amegroups.org/article/view/68883} }